Get the Stockscreener App
1.93
2.66%
0.05
After Hours:
1.90
-0.03
-1.55%
Q 32 Bio Inc stock is traded at $1.93, with a volume of 58,222.
It is up +2.66% in the last 24 hours and up +14.88% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.88
Open:
$1.96
24h Volume:
58,222
Relative Volume:
0.05
Market Cap:
$23.54M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+15.57%
1M Performance:
+14.88%
6M Performance:
+1.58%
1Y Performance:
-95.75%
1-Day Range:
$1.83
$2.00
1-Week Range:
$1.68
$2.00
52-Week Range:
$1.345
$53.17
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.93 | 21.71M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Applying Elliott Wave Theory to Q32 Bio Inc.2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Detecting support and resistance levels for Q32 Bio Inc.July 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Backtesting results for Q32 Bio Inc. trading strategiesWall Street Watch & Expert Curated Trade Setups - newser.com
Statistical indicators supporting Q32 Bio Inc.’s strength2025 Pullback Review & Reliable Breakout Forecasts - newser.com
Chart overlay techniques for tracking Q32 Bio Inc.Inflation Watch & Breakout Confirmation Alerts - newser.com
News impact scoring models applied to Q32 Bio Inc.July 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com
What to do if you’re stuck in Q32 Bio Inc.July 2025 Trends & Intraday High Probability Alerts - newser.com
Short interest data insights for Q32 Bio Inc.Market Performance Recap & Consistent Profit Alerts - newser.com
How to forecast Q32 Bio Inc. trends using time seriesDividend Hike & Low Drawdown Trading Strategies - newser.com
Analyzing Q32 Bio Inc. with multi timeframe chartsQuarterly Investment Review & Safe Entry Trade Reports - newser.com
Will Q32 Bio Inc. stock recover after recent dropLayoff News & Weekly Top Stock Performers List - newser.com
Is now a turning point for Q32 Bio Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Visual analytics tools that track Q32 Bio Inc. performance2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
Multi asset correlation models including Q32 Bio Inc.New Guidance & Accurate Buy Signal Notifications - Newser
Will earnings trigger a reversal in Q32 Bio Inc.2025 Valuation Update & Advanced Technical Analysis Signals - Newser
What indicators show strength in Q32 Bio Inc.2025 Trade Ideas & Daily Profit Focused Stock Screening - Newser
Ranking Q32 Bio Inc. among high performing stocks via tools2025 Analyst Calls & AI Driven Stock Reports - Newser
How to manage a losing position in Q32 Bio Inc.Rate Cut & Daily Risk Controlled Trade Plans - Newser
Does Q32 Bio Inc. fit your quant trading modelPortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
Using flow based indicators on Q32 Bio Inc.Volume Spike & Expert Curated Trade Setups - Newser
Real time social sentiment graph for Q32 Bio Inc.Quarterly Profit Review & Short-Term High Return Strategies - Newser
Published on: 2025-09-12 05:24:02 - Newser
Tools to monitor Q32 Bio Inc. recovery probabilityLayoff News & Community Consensus Stock Picks - Newser
Real time scanner hits for Q32 Bio Inc. explainedFed Meeting & Weekly High Return Stock Forecasts - Newser
Developing predictive dashboards with Q32 Bio Inc. dataEarnings Recap Summary & AI Driven Stock Movement Reports - Newser
Is it too late to sell Q32 Bio Inc.Quarterly Investment Review & Daily Growth Stock Tips - Newser
Momentum divergence signals in Q32 Bio Inc. chartJuly 2025 Outlook & Daily Chart Pattern Signals - Newser
Will Q32 Bio Inc. stock go up soonTrade Analysis Summary & Target Return Focused Picks - Newser
Analyzing Q32 Bio Inc. with risk reward ratio chartsJuly 2025 Setups & Low Risk Profit Maximizing Plans - Newser
Will Q32 Bio Inc. continue its uptrendJuly 2025 Opening Moves & Safe Entry Zone Tips - Newser
Q32 Bio Inc. stock daily chart insightsMarket Performance Recap & Low Drawdown Investment Ideas - Newser
Is Q32 Bio Inc. a potential multi baggerTrade Ideas & Reliable Entry Point Trade Alerts - Lancaster City Council
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):